MedTech News
.................... by Andrew Celentano
Drug combination that reduces oxygen levels in tissues improves Parkinson’s symptoms in mice
In a new study, Broad Institute researchers report that two small-molecule chemicals that reduce oxygen delivery to cells improved symptoms of neurodegeneration in a mouse model of Parkinson’s disease.
Stem cell–like tumor state may help identify high-risk small-cell lung cancer
Northwestern Medicine scientists have identified a stem-like state in small-cell lung cancer that distinguishes a group of patients with exceptionally poor outcomes following chemoimmunotherapy, according to a study published in Cell Reports Medicine.
The shape of water at a key tau hotspot helps drive dementia-linked clumping
Diseases such as Alzheimer’s and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline. Until now, it has been unclear how misfolded tau recruits other seemingly healthy tau and causes it to misfold and clump.
Tiny robots speed medicine through body to the heart
Johns Hopkins University engineers have created robots the size of a pencil tip intended to travel through the body to deliver medicine to infections inside a beating heart.
Two-trigger drugs target ‘zombie’ cancer cells with sharper aim
Stopping a cancer cell from dividing does not necessarily make it harmless. Chemotherapy can leave behind living, senescent cells. These ‘zombie’ cells can release inflammatory signals, helping tumors resist treatment. Drugs that eliminate these lingering cells could help, but they can also harm other cells.
New World Medical Receives MDR Certification for Ahmed® Glaucoma Valve, Ahmed ClearPath®, and KDB GLIDE
RANCHO CUCAMONGA, Calif., Oct. 6, 2026 /PRNewswire/ — New World Medical is pleased to announce the Ahmed® Glaucoma Valve (AGV), Ahmed ClearPath® (ACP), and KDB GLIDE® have received Medical Device Regulation (MDR) certification in the European Union.
E2 Secures Dual FDA Clearances for the Hēlo® Platform, Introducing a PE Thrombectomy System with Integrated Blood Return
Combination of Hēlo Thrombectomy System and Hēlo Return establish the first 510(k)-cleared platform compatible with continuous vacuum aspiration
RingConn Receives FDA 510(k) Clearance for Non-Invasive Blood Oxygen (SpO2) Measurement
Shenzhen, China, Oct. 10, 2026 /PRNewswire/ — Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No. K260490).